In clinical practices, studies demonstrated that elevated serum CHI3L1 levels were independently associated with coronary artery disease, and patients with the severity of coronary atherosclerosis had higher CHI3L1 levels (Kucur et al., 2007; Sui and Gao, 2013). This evidence concerns the gene CHI3L1 and coronary artery disorder.